No worries thigrlsrk. He can say whatever he wants, it doesn't change anything. For anyone near me, I do still have the voicemail, email, and cell phone log to prove what I say is true. Better yet, they can simply call IR themselves and they will get the same answer for validation.
SRPT investor relations. I was impressed with the gentlemans knowledge, understanding, and level of information he was willing to share. If he maintains the same level of professionalism with the big fund managers, it bodes very well for SRPT.
The CEO has a rock solid reputation with the FDA as well as with fund managers who are investing billions of dollars in the market.
It does appear that there are one or two people on the Yahoo boards posting from their Mommy's basement who don't like him, but that's pretty much it.
I asked and got a very informative answer. They were quite clear. YES they will file with the FDA THIS YEAR. And YES that means by 12/31/2014.
1) DMD - NDA Submission (AA)
2) Enrollment for Phase III Trials
3) 4th dystrophin biopsys
4) 168-week data in January which should hold some very very good results.
I spoke with an extremely nice gentleman from IR who confirmed that they are on-schedule to file with the FDA on Eteplirsen. He was extremely professional and informative. SRPT is lucky to have a person like that in the IR role. He represents them well.
I got burned badly on CCME (google it) and won't buy another Chinese scam stock ever again.
I got burned by a Chinese scam stock CCME that was audited by Deloitte, traded on the Nasdaq, seemed all well and good. Some investigative journalists went to China, met with customers, saw the ads, seemed able to validate everything. Uh, until they halted trading, auditors backed away from their certification, and stock became worthless.
It was a massive Chinese scam.
Even with Deloitte as the auditor and several independent investigative reporters flying to China to check out CCME, to see the advertising at work, talk to customers, see the operation -- it all turned out to be a SCAM. Google it and read about it. The stock was halted on the Nasdaq and the shares are still stuck in my account, unable to trade.
Be VERY careful with these Chinese crooks. They will steal your money.
No, and if it is anything like the China Media Express (CCME) scam, this whole thing could come crashing down in the worst way. CCME was halted and went to ZERO despite being audited by Deloitte who later backed away from their audits, pretending they didn't know about the fraud.
Be VERY careful with these Chinese crooks.
Because people like me got burned on Chinese stocks like CCME that was audited by Deloitte until they figured out the whole thing was a sham and none of it real.
I fell for a similar Chinese scam with the ticker CCME. Traded on the Nasdaq, audited by Deloitte until OOPS, they realized the whole thing was FRAUD. Gone in a moment. Halted tradi, nothing else ever done.
Chinese stocks are scams...
CCME burns because nobody DID anything. Nobody held Deloitte or the Nasdaq accountable for the fraud. They all just let the Chinese crooks get away with it.
I hope it works for you - as I got burned by a Chinese scam company.
I got caught owning some CCME (China Media Express) that owned advertising space on city buses, stops, etc., and had a virtual monopoly on the market. They bragged that they were China’s largest TV advertising operator on inter-city and airport express buses, It traded on the Nasdaq
They had a Big-6 Accounting firm (Deloitte) that audited their books but then it all unraveled quickly as a Chinese SCAM and apparently they faked everything. So then Deloitte backed out saying they wouldn't certify the latest numbers and the whole thing fell apart. What appeared to be a legitimate thriving business was nothing but a scam. Those shares were halted several years ago and you can't sell them at any price now.
So beware the CHINESE scam marketers, what seems like a good deal may not be when held under the bright light of scrutiny. The lessons learned were many:
1) The Chinese do not have the same rigorous controls on financial audits that we do in the USA.
2) You can't trust even a Big-6 Accounting Firm like Deloitte (who actually certified the CCME results through a Chinese affiliate - or at least that was their defense).
3) You can't trust the Nasdaq to validate a company is legitimate.
4) Even people (USA Journalists) who went to China, rode the buses, saw the ads, talked to customers who allegedly advertised through CCME, were fooled - so there is no real amount of DD that is "enough".
5) I'll never buy into another Chinese company again. The burned hand teaches best. Sure I have bought things through Alibaba and it may prove to be an OK investment, but there is no way in hell I'm going to make the same mistake again. China is simply too dangerous a market without proper monitoring or controls.
If you think Alibaba is the greatest thing since sliced bread, then that is fine. I don't own any long or short (well, you can't short it yet anyway). All I want to do is urge you to be careful and hopefully learn from my mistake.
One thing that I haven't heard much discussion on is the indirect benefit of Eteplirsen. Namely, even if the drug doesn't cure, only slows (or halts) the degeneration, it buys these children time while other therapies are developed and other drugs created. That extends the time frame each of them have to get the help that will cure them for good.
This has really fallen far too much too fast for no reason. The Macro level picture hasn't changed at all and the institutional investors I've talked to say this is a general market drawdown and nothing specific to SRPT at all. Their advice to me was to take advantage of the buying opportunity because 6-months from now it will have doubled.
Do you really not understand how the markets work, or are you just a short pretending to be dumb? Here is the reason. If you try to buy $100M of stock, it will drive the price up substantially. $100M of stock at $38/share is 2.63M shares of stock. With an average daily volume of 1,527,760/day this would create a HUGE spike in the share price, probably driving it up to $50 or $60 in a few days. Therefore, getting it at a bulk rate discount at $38 is a great deal.
Combine that with the fact that those that bought it at $38 will probably come buy MORE to drive up their investment, it will quickly rise to about $50/share before trading sideways for a bit.